BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 8828142)

  • 21. Presence of a Shared 5'-Leader Sequence in Ancestral Human and Mammalian Retroviruses and Its Transduction into Feline Leukemia Virus.
    Kawasaki J; Kawamura M; Ohsato Y; Ito J; Nishigaki K
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein.
    Brojatsch J; Kristal BS; Viglianti GA; Khiroya R; Hoover EA; Mullins JI
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8457-61. PubMed ID: 1326757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome.
    Chandhasin C; Coan PN; Pandrea I; Grant CK; Lobelle-Rich PA; Puetter A; Levy LS
    J Virol; 2005 May; 79(9):5278-87. PubMed ID: 15827142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Copper Transporter 1 as a Receptor for Feline Endogenous Retrovirus ERV-DC14.
    Tury S; Giovannini D; Ivanova S; Touhami J; Courgnaud V; Battini JL
    J Virol; 2022 Jun; 96(12):e0022922. PubMed ID: 35652657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal processing of a recombinant feline leukemia virus envelope polyprotein and its interference with subgroup C virus infection.
    Bechtel MK; Stallcup MR; Bedgood RM; Corey JL; Pandey R; Roy-Burman P
    Virology; 1994 Jul; 202(1):329-38. PubMed ID: 8009844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses.
    Stewart MA; Warnock M; Wheeler A; Wilkie N; Mullins JI; Onions DE; Neil JC
    J Virol; 1986 Jun; 58(3):825-34. PubMed ID: 3009890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are endogenous feline leukemia viruses really endogenous?
    Stewart H; Jarrett O; Hosie MJ; Willett BJ
    Vet Immunol Immunopathol; 2011 Oct; 143(3-4):325-31. PubMed ID: 21715022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant.
    Rohn JL; Moser MS; Gwynn SR; Baldwin DN; Overbaugh J
    J Virol; 1998 Apr; 72(4):2686-96. PubMed ID: 9525586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of feline leukemia virus subgroup A infection by coinoculation with subgroup B.
    Phipps AJ; Hayes KA; Al-dubaib M; Roy-Burman P; Mathes LE
    Virology; 2000 Nov; 277(1):40-7. PubMed ID: 11062034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors.
    Rohn JL; Linenberger ML; Hoover EA; Overbaugh J
    J Virol; 1994 Apr; 68(4):2458-67. PubMed ID: 8139030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses.
    Donahue PR; Hoover EA; Beltz GA; Riedel N; Hirsch VM; Overbaugh J; Mullins JI
    J Virol; 1988 Mar; 62(3):722-31. PubMed ID: 2828667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in understanding molecular determinants in FeLV pathology.
    Levy LS
    Vet Immunol Immunopathol; 2008 May; 123(1-2):14-22. PubMed ID: 18289704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.
    Nishigaki K; Hanson C; Thompson D; Yugawa T; Hisasue M; Tsujimoto H; Ruscetti S
    J Virol; 2002 Feb; 76(3):1527-32. PubMed ID: 11773427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors.
    Moser M; Burns CC; Boomer S; Overbaugh J
    Virology; 1998 Mar; 242(2):366-77. PubMed ID: 9514965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma.
    Rohn JL; Lauring AS; Linenberger ML; Overbaugh J
    J Virol; 1996 Nov; 70(11):8071-80. PubMed ID: 8892932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel truncated env gene isolated from a feline leukemia virus-induced thymic lymphosarcoma.
    Shi Y; Roy-Burman P
    J Virol; 2000 Feb; 74(3):1451-6. PubMed ID: 10627556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytopathic feline leukemia viruses cause apoptosis in hemolymphatic cells.
    Rojko JL; Hartke JR; Cheney CM; Phipps AJ; Neil JC
    Prog Mol Subcell Biol; 1996; 16():13-43. PubMed ID: 8822790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The surface glycoprotein of feline leukemia virus isolate FeLV-945 is a determinant of altered pathogenesis in the presence or absence of the unique viral long terminal repeat.
    Bolin LL; Ahmad S; Lobelle-Rich PA; Ooms TG; Alvarez-Hernandez X; Didier PJ; Levy LS
    J Virol; 2013 Oct; 87(19):10874-83. PubMed ID: 23903838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ancestral Mutations Acquired in Refrex-1, a Restriction Factor against Feline Retroviruses, during its Cooption and Domestication.
    Ito J; Baba T; Kawasaki J; Nishigaki K
    J Virol; 2016 Feb; 90(3):1470-85. PubMed ID: 26581999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
    Chandhasin C; Coan PN; Levy LS
    J Virol; 2005 Feb; 79(3):1351-60. PubMed ID: 15650161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.